MUMBAI Feb 6 Cipla Ltd, India's fifth
largest drugmaker by sales, reported a 25.5 percent rise in
quarterly profit on robust sales but slightly missed street
estimates as taxes surged.
The Mumbai-based drugmaker said, net profit grew to 3.39
billion rupees ($63.81 million) in October-December from 2.7
billion rupees a year earlier. Analysts on an average had
expected a net profit of 3.48 billion rupees, according to
Thomson Reuters I/B/E/S.
Sales rose 18.65 percent to 20.3 billion rupees, it said.
Shares in Cipla fell 0.56 percent to 405 rupees on Wednesday
when the Mumbai market closed down 0.1 percent.
($1 = 53.12 rupees)
(Reporting by Kaustubh Kulkarni; Editing by Anand Basu)